A new treatment option is available for adults with advanced pancreatic cancer. The FDA has approved a once-daily pill for this condition, providing an alternative for patients.

This approval was made by U.S. health regulators, according to the FDA. The pill is intended for adults with advanced pancreatic cancer.

Further information on this approval can be found through the FDA, as details of the treatment and its implications are available from this source.